Podcast

Knowing Your Hereditary Risk

Author(s):

In this special edition of the CURE Talks Cancer podcast, we kick off National Hereditary Breast and Ovarian Cancer Week and Previvor Day.

In 2010, history was made when a Congressional resolution was passed to declare the first-ever National Hereditary Breast and Ovarian Cancer Week and National Previvor Day to raise awareness about hereditary cancer.

Millions of people carry an inherited mutation or have a family history of cancer but many don't know about their risk. National Hereditary Breast and Ovarian Cancer Week and Previvor Day aim to change that.

In this special edition of the CURE Talks Cancer, we spoke with president and CEO of My Gene Counsel, Ellen Matloff, and founder of Proactive Genes, Shannon Pulaski, to help kick off National Hereditary Breast and Ovarian Cancer Week and Previvor Day. In this episode you’ll hear about their resources and how each can help others learn more about their hereditary risk.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Related Content